1. Home
  2. LGCB vs RVPH Comparison

LGCB vs RVPH Comparison

Compare LGCB & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGCB
  • RVPH
  • Stock Information
  • Founded
  • LGCB 2011
  • RVPH 2006
  • Country
  • LGCB Japan
  • RVPH United States
  • Employees
  • LGCB 92
  • RVPH N/A
  • Industry
  • LGCB
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGCB
  • RVPH Health Care
  • Exchange
  • LGCB Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • LGCB 19.7M
  • RVPH 18.1M
  • IPO Year
  • LGCB 2023
  • RVPH N/A
  • Fundamental
  • Price
  • LGCB $1.97
  • RVPH $0.48
  • Analyst Decision
  • LGCB
  • RVPH Strong Buy
  • Analyst Count
  • LGCB 0
  • RVPH 6
  • Target Price
  • LGCB N/A
  • RVPH $4.50
  • AVG Volume (30 Days)
  • LGCB 3.0M
  • RVPH 19.0M
  • Earning Date
  • LGCB 07-03-2025
  • RVPH 11-13-2025
  • Dividend Yield
  • LGCB N/A
  • RVPH N/A
  • EPS Growth
  • LGCB N/A
  • RVPH N/A
  • EPS
  • LGCB N/A
  • RVPH N/A
  • Revenue
  • LGCB $8,993,265.00
  • RVPH N/A
  • Revenue This Year
  • LGCB N/A
  • RVPH N/A
  • Revenue Next Year
  • LGCB N/A
  • RVPH N/A
  • P/E Ratio
  • LGCB N/A
  • RVPH N/A
  • Revenue Growth
  • LGCB 5.80
  • RVPH N/A
  • 52 Week Low
  • LGCB $1.22
  • RVPH $0.25
  • 52 Week High
  • LGCB $6.83
  • RVPH $4.28
  • Technical
  • Relative Strength Index (RSI)
  • LGCB 48.53
  • RVPH 46.76
  • Support Level
  • LGCB $1.67
  • RVPH $0.57
  • Resistance Level
  • LGCB $3.10
  • RVPH $0.69
  • Average True Range (ATR)
  • LGCB 0.22
  • RVPH 0.11
  • MACD
  • LGCB 0.02
  • RVPH -0.01
  • Stochastic Oscillator
  • LGCB 23.67
  • RVPH 23.63

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: